{"address1": "455 Mission Bay Boulevard South", "city": "San Francisco", "state": "CA", "zip": "94158", "country": "United States", "phone": "415 482 5300", "fax": "415 339 5300", "website": "https://www.nektar.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally. It develops NKTR-358, a regulatory T (Treg) cell stimulator designed to address the imbalance in the immune system underlying autoimmune disorders and chronic inflammatory conditions; PEG-CSF1, a polyethylene glycol (PEG) modified hematopoietic colony stimulating factor protein that is engineered to selectively modulate resolution processes of inflammation and has applications in a number of therapeutic indications, including acute and chronic inflammation; Tumor necrosis factor (TNF) receptor type II (TNFR2) agonist asset is a bivalent antibody molecule used to selectively stimulate TNFR2 receptor activity, without modulation of the TNFR1 signaling; and NKTR-255, an IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.", "fullTimeEmployees": 61, "companyOfficers": [{"maxAge": 1, "name": "Mr. Howard W. Robin", "age": 71, "title": "CEO, President & Director", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 2166571, "exercisedValue": 0, "unexercisedValue": 186333}, {"maxAge": 1, "name": "Ms. Sandra A. Gardiner", "age": 58, "title": "CFO and Principal Financial & Accounting Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 460850, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark A. Wilson J.D.", "age": 52, "title": "Senior VP, Chief Legal Officer & Secretary", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 898297, "exercisedValue": 0, "unexercisedValue": 46583}, {"maxAge": 1, "name": "Dr. Jonathan  Zalevsky Ph.D.", "age": 49, "title": "Senior VP and Chief Research & Development Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 1151200, "exercisedValue": 0, "unexercisedValue": 35833}, {"maxAge": 1, "name": "Mr. Jason  Barnard", "title": "Chief Accounting Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Vivian  Wu", "title": "Director of Investor Relations & Corporate Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Bacci", "title": "Chief People Officer and Head of Quality & Facilities", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Ruddock", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brian L. Kotzin M.D.", "age": 74, "title": "Interim Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 2, "overallRisk": 6, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.nektar.com/", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.68, "open": 0.69, "dayLow": 0.6373, "dayHigh": 0.694, "regularMarketPreviousClose": 0.68, "regularMarketOpen": 0.69, "regularMarketDayLow": 0.6373, "regularMarketDayHigh": 0.694, "payoutRatio": 0.0, "beta": 0.655, "forwardPE": -0.82766235, "volume": 2221835, "regularMarketVolume": 2221835, "averageVolume": 2109575, "averageVolume10days": 1717200, "averageDailyVolume10Day": 1717200, "bid": 0.6248, "ask": 0.6637, "bidSize": 15, "askSize": 15, "marketCap": 118604080, "fiftyTwoWeekLow": 0.6373, "fiftyTwoWeekHigh": 1.93, "priceToSalesTrailing12Months": 1.2049954, "fiftyDayAverage": 0.8354, "twoHundredDayAverage": 1.1109, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 57717816, "profitMargins": -1.20862, "floatShares": 173991966, "sharesOutstanding": 186104000, "sharesShort": 6947547, "sharesShortPriorMonth": 7477125, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0373, "heldPercentInsiders": 0.01263, "heldPercentInstitutions": 0.71913004, "shortRatio": 3.38, "shortPercentOfFloat": 0.0476, "impliedSharesOutstanding": 186104000, "bookValue": 0.327, "priceToBook": 1.9489298, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -118961000, "trailingEps": -0.58, "forwardEps": -0.77, "lastSplitFactor": "2:1", "lastSplitDate": 966988800, "enterpriseToRevenue": 0.586, "enterpriseToEbitda": -0.46, "52WeekChange": -0.38461536, "SandP52WeekChange": 0.08089435, "lastDividendValue": 0.0, "lastDividendDate": 1402444800, "quoteType": "EQUITY", "currentPrice": 0.6373, "targetHighPrice": 7.0, "targetLowPrice": 1.0, "targetMeanPrice": 4.75, "targetMedianPrice": 5.0, "recommendationMean": 2.125, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 255226000, "totalCashPerShare": 1.371, "ebitda": -125527000, "totalDebt": 194340000, "quickRatio": 4.183, "currentRatio": 4.256, "totalRevenue": 98427000, "debtToEquity": 319.97, "revenuePerShare": 0.479, "returnOnAssets": -0.23136999, "returnOnEquity": -1.24096, "grossProfits": 67741000, "freeCashflow": -43692752, "operatingCashflow": -175708992, "revenueGrowth": 0.221, "grossMargins": 0.68824, "ebitdaMargins": -1.27533, "operatingMargins": -0.84599996, "financialCurrency": "USD", "symbol": "NKTR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -0.58, "epsForward": -0.77, "epsCurrentYear": -0.71703, "priceEpsCurrentYear": -0.88880527, "fiftyDayAverageChange": -0.19809997, "fiftyDayAverageChangePercent": -0.23713188, "twoHundredDayAverageChange": -0.47360003, "twoHundredDayAverageChangePercent": -0.426321, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.1 - Buy", "cryptoTradeable": false, "marketState": "PRE", "regularMarketChangePercent": -6.2794104, "regularMarketPrice": 0.6373, "shortName": "Nektar Therapeutics", "longName": "Nektar Therapeutics", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 767971800000, "preMarketChange": -0.0073000193, "preMarketChangePercent": -1.1454604, "preMarketPrice": 0.63, "regularMarketChange": -0.042699993, "regularMarketDayRange": "0.6373 - 0.694", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2109575, "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "0.6373 - 1.93", "fiftyTwoWeekHighChange": -1.2926999, "fiftyTwoWeekHighChangePercent": -0.6697927, "fiftyTwoWeekChangePercent": -38.461536, "earningsTimestamp": 1741810504, "earningsTimestampStart": 1746615540, "earningsTimestampEnd": 1747051200, "earningsCallTimestampStart": 1741813200, "earningsCallTimestampEnd": 1741813200, "isEarningsDateEstimate": true, "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "preMarketTime": 1743596371, "regularMarketTime": 1743537600, "exchange": "NCM", "messageBoardId": "finmb_29929", "trailingPegRatio": null}